Gland Pharma profit rises 12 percent to Rs 184 crore in Q2
Written By : Ruchika Sharma
Published On 2025-11-04 09:32 GMT | Update On 2025-11-04 09:32 GMT
Advertisement
Gland Pharma Ltd has posted a 12 per cent year-on-year rise in profit after tax (PAT) at Rs 84 crore for the quarter ended September 2025, supported by robust contributions from its CDMO subsidiary, Cenexi.
In the same period last fiscal, the Hyderabad-based pharmaceutical firm had reported a PAT of Rs 163 crore.
Revenue from operations grew to Rs 1,487 crore in the July–September quarter, compared to Rs 1,406 crore in the corresponding quarter of the previous fiscal, the company said.
Shyamakant Giri, Chief Executive Officer of Gland Pharma, said, “For the quarter, Gland Pharma’s core business maintained its profitable growth trajectory with strong margin expansion. Encouragingly for consolidated business, we saw year-over-year improvement during the Q2 FY26 with USA growing by 10% and Europe by 16%, supported by a 21% top-line increase in Cenexi. With the current momentum, we anticipate a robust growth in the upcoming quarters.”
Gland Pharma was established in 1978 in Hyderabad. The company has a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India, and other markets. It operates primarily under a business-to-business (B2B) model. It has a wide range of injectables, including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions, oncology, and ophthalmic solutions.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.